Literature DB >> 28436975

Haploidentical stem cell transplantation with CD3+-/CD19+- depleted peripheral stem cells for patients with advanced stage sickle cell disease and no alternative donor: results of a pilot study.

J Foell1, B Pfirstinger1, K Rehe1, D Wolff2, E Holler2, S Corbacioglu1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28436975     DOI： 10.1038/bmt.2017.49

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  15 in total

Review 1.  Allogeneic transplantation strategies including haploidentical transplantation in sickle cell disease.

Authors:  Eliane Gluckman
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2013

Review 2.  Immune reconstitution and strategies for rebuilding the immune system after haploidentical stem cell transplantation.

Authors:  Lena Oevermann; Peter Lang; Tobias Feuchtinger; Michael Schumm; Heiko-Manuel Teltschik; Patrick Schlegel; Rupert Handgretinger
Journal:  Ann N Y Acad Sci       Date:  2012-08       Impact factor: 5.691

Review 3.  The current role of T cell depletion in paediatric stem cell transplantation.

Authors:  Claire Booth; Sarah Lawson; Paul Veys
Journal:  Br J Haematol       Date:  2013-05-30       Impact factor: 6.998

4.  Matched-related donor transplantation for sickle cell disease: report from the Center for International Blood and Transplant Research.

Authors:  Julie A Panepinto; Mark C Walters; Jeanette Carreras; Judith Marsh; Christopher N Bredeson; Robert Peter Gale; Gregory A Hale; John Horan; Jill M Hows; John P Klein; Ricardo Pasquini; Irene Roberts; Keith Sullivan; Mary Eapen; Alina Ferster
Journal:  Br J Haematol       Date:  2007-04-24       Impact factor: 6.998

5.  HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. registry.

Authors:  Loren Gragert; Mary Eapen; Eric Williams; John Freeman; Stephen Spellman; Robert Baitty; Robert Hartzman; J Douglas Rizzo; Mary Horowitz; Dennis Confer; Martin Maiers
Journal:  N Engl J Med       Date:  2014-07-24       Impact factor: 91.245

Review 6.  Blood and marrow transplantation for sickle cell disease: is less more?

Authors:  Javier Bolaños-Meade; Robert A Brodsky
Journal:  Blood Rev       Date:  2014-08-27       Impact factor: 8.250

7.  Outcome of patients with hemoglobinopathies given either cord blood or bone marrow transplantation from an HLA-identical sibling.

Authors:  Franco Locatelli; Nabil Kabbara; Annalisa Ruggeri; Ardeshir Ghavamzadeh; Irene Roberts; Chi Kong Li; Françoise Bernaudin; Christiane Vermylen; Jean-Hugues Dalle; Jerry Stein; Robert Wynn; Catherine Cordonnier; Fernando Pinto; Emanuele Angelucci; Gérard Socié; Eliane Gluckman; Mark C Walters; Vanderson Rocha
Journal:  Blood       Date:  2013-05-21       Impact factor: 22.113

Review 8.  Sickle red cell-endothelium interactions.

Authors:  Dhananjay K Kaul; Eileen Finnegan; Gilda A Barabino
Journal:  Microcirculation       Date:  2009-01       Impact factor: 2.628

9.  HLA-haploidentical bone marrow transplantation with posttransplant cyclophosphamide expands the donor pool for patients with sickle cell disease.

Authors:  Javier Bolaños-Meade; Ephraim J Fuchs; Leo Luznik; Sophie M Lanzkron; Christopher J Gamper; Richard J Jones; Robert A Brodsky
Journal:  Blood       Date:  2012-09-06       Impact factor: 22.113

10.  Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease.

Authors:  Françoise Bernaudin; Gérard Socie; Mathieu Kuentz; Sylvie Chevret; Michel Duval; Yves Bertrand; Jean-Pierre Vannier; Karima Yakouben; Isabelle Thuret; Pierre Bordigoni; Alain Fischer; Patrick Lutz; Jean-Louis Stephan; Nathalie Dhedin; Emmanuel Plouvier; Geneviève Margueritte; Dominique Bories; Suzanne Verlhac; Hélène Esperou; Lena Coic; Jean-Paul Vernant; Eliane Gluckman
Journal:  Blood       Date:  2007-07-02       Impact factor: 22.113
View more
  7 in total

Review 1.  How I treat sickle cell disease with hematopoietic cell transplantation.

Authors:  Elizabeth O Stenger; Shalini Shenoy; Lakshmanan Krishnamurti
Journal:  Blood       Date:  2019-12-19       Impact factor: 22.113

2.  Hematopoietic cell transplantation for sickle cell disease: updates and future directions.

Authors:  Lakshmanan Krishnamurti
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

3.  Long-term Survival after Hematopoietic Cell Transplant for Sickle Cell Disease Compared to the United States Population.

Authors:  Andrew St Martin; Kyle M Hebert; Arnaud Serret-Larmande; Vianney Jouhet; Emily Hughes; Jason Stedman; Thomas DeSain; Danielle Pillion; Jessica C Lyons; Patricia Steinert; Paul Avillach; Mary Eapen
Journal:  Transplant Cell Ther       Date:  2022-03-15

4.  American Society of Hematology 2021 guidelines for sickle cell disease: stem cell transplantation.

Authors:  Julie Kanter; Robert I Liem; Françoise Bernaudin; Javier Bolaños-Meade; Courtney D Fitzhugh; Jane S Hankins; M Hassan Murad; Julie A Panepinto; Damiano Rondelli; Shalini Shenoy; John Wagner; Mark C Walters; Teonna Woolford; Joerg J Meerpohl; John Tisdale
Journal:  Blood Adv       Date:  2021-09-28

5.  Early Myeloid Derived Suppressor Cells (eMDSCs) Are Associated With High Donor Myeloid Chimerism Following Haploidentical HSCT for Sickle Cell Disease.

Authors:  Deepali K Bhat; Purevdorj B Olkhanud; Arunakumar Gangaplara; Fayaz Seifuddin; Mehdi Pirooznia; Angélique Biancotto; Giovanna Fantoni; Corinne Pittman; Berline Francis; Pradeep K Dagur; Ankit Saxena; J Philip McCoy; Ruth M Pfeiffer; Courtney D Fitzhugh
Journal:  Front Immunol       Date:  2021-11-30       Impact factor: 7.561

6.  Debating the Future of Sickle Cell Disease Curative Therapy: Haploidentical Hematopoietic Stem Cell Transplantation vs. Gene Therapy.

Authors:  Adetola A Kassim; Alexis Leonard
Journal:  J Clin Med       Date:  2022-08-16       Impact factor: 4.964

Review 7.  Why, Who, When, and How? Rationale for Considering Allogeneic Stem Cell Transplantation in Children with Sickle Cell Disease.

Authors:  Françoise Bernaudin
Journal:  J Clin Med       Date:  2019-09-22       Impact factor: 4.241
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.